The Endothelin System and Endothelin-Converting Enzyme in the Brain: Molecular and Cellular Studies

被引:0
|
作者
Kay Barnes
Anthony J. Turner
机构
[1] University of Leeds,Department of Biochemistry and Molecular Biology
来源
Neurochemical Research | 1997年 / 22卷
关键词
Endothelin; endothelin converting enzyme; metalloprotease; neutral endopeptidase; amino-peptidases;
D O I
暂无
中图分类号
学科分类号
摘要
The biologically active vasoactive peptides, the endothelins (ETs), are generated from inactive intermediates, the big endothelins, by a unique processing event catalysed by the zinc metalloprotease, endothelin converting enzyme (ECE). In this overview we examine the actions of endothelins in the brain, and focus on the structure and cellular locations of ECE. The heterogeneous distribution in the brain of ET-1, ET-2, and ET-3 is discussed in relation to their hemodynamic, mitogenic and proliferative properties as well as their possible roles as neurotransmitters. The cellular and subcellular localization of ECE in neuronal and in glial cells is compared with that of other brain membrane metalloproteases, neutral endopeptidase-24.11 (neprilysin), angiotensin converting enzyme and aminopeptidase N, which all function in neuropeptide processing and metabolism. Unlike these ectoenzymes, ECE exhibits a dual localisation in the cell, being present on the plasma membrane and also, in some instances, being concentrated in a perinuclear region. This differential localization may reflect distinct targeting of different ECE isoforms, ECE-lα, ECE-1β, and ECE-2.
引用
收藏
页码:1033 / 1040
页数:7
相关论文
共 50 条
  • [1] The endothelin system and endothelin-converting enzyme in the brain: Molecular and cellular studies
    Barnes, K
    Turner, AJ
    NEUROCHEMICAL RESEARCH, 1997, 22 (08) : 1033 - 1040
  • [2] Endothelin-converting enzyme inhibitors:: Current status and perspectives
    Löffler, BM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 : S79 - S82
  • [3] Endothelin-converting enzyme: Its functional aspect
    Gomazkov, OA
    BIOCHEMISTRY-MOSCOW, 1998, 63 (02) : 125 - 132
  • [4] Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1
    Takayanagi, R
    Liu, W
    Ito, T
    Ohnaka, K
    Nawata, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S62 - S63
  • [5] MOLECULAR MODELING OF THE ACTIVE-SITE OF ENDOTHELIN-CONVERTING ENZYME
    SANSOM, CE
    HOANG, VM
    TURNER, AJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S75 - S77
  • [6] Cellular distribution of endothelin-converting enzyme-1 in human tissues
    Korth, P
    Bohle, RM
    Corvol, P
    Pinet, F
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (04) : 447 - 461
  • [7] ENDOTHELIN-CONVERTING ENZYMES
    OPGENORTH, TJ
    WUWONG, JR
    SHIOSAKI, K
    FASEB JOURNAL, 1992, 6 (09) : 2653 - 2659
  • [8] Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure
    Zolk, O
    Quattek, J
    Sitzler, G
    Schrader, T
    Nickenig, G
    Schnabel, P
    Shimada, K
    Takahashi, M
    Böhm, M
    CIRCULATION, 1999, 99 (16) : 2118 - 2123
  • [9] Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans
    Shirai, N
    Naruko, T
    Ohsawa, M
    Ikura, Y
    Sugama, Y
    Hirayama, M
    Kitabayashi, C
    Ehara, S
    Inoue, T
    Itoh, A
    Haze, K
    Tanzawa, K
    Yoshiyama, M
    Yoshikawa, J
    Ueda, M
    JOURNAL OF HYPERTENSION, 2006, 24 (04) : 711 - 721
  • [10] Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications
    Jeng, AY
    Mulder, P
    Kwan, AL
    Battistini, B
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) : 440 - 449